CN109601980A - A kind of PUFA soft capsule and preparation method thereof containing sialic acid - Google Patents
A kind of PUFA soft capsule and preparation method thereof containing sialic acid Download PDFInfo
- Publication number
- CN109601980A CN109601980A CN201811358736.0A CN201811358736A CN109601980A CN 109601980 A CN109601980 A CN 109601980A CN 201811358736 A CN201811358736 A CN 201811358736A CN 109601980 A CN109601980 A CN 109601980A
- Authority
- CN
- China
- Prior art keywords
- pufa
- oil
- sialic acid
- parts
- soft capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title claims abstract description 111
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 title claims abstract description 106
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 title claims abstract description 105
- 239000007901 soft capsule Substances 0.000 title claims abstract description 51
- 238000002360 preparation method Methods 0.000 title abstract description 41
- 239000012053 oil suspension Substances 0.000 claims abstract description 55
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 14
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 14
- 238000005259 measurement Methods 0.000 claims abstract description 3
- 239000003921 oil Substances 0.000 claims description 86
- 235000019198 oils Nutrition 0.000 claims description 86
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 75
- 239000007788 liquid Substances 0.000 claims description 39
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 36
- 238000000227 grinding Methods 0.000 claims description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- 238000010790 dilution Methods 0.000 claims description 14
- 239000012895 dilution Substances 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 235000006708 antioxidants Nutrition 0.000 claims description 13
- 108010010803 Gelatin Proteins 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 12
- 239000008273 gelatin Substances 0.000 claims description 12
- 229920000159 gelatin Polymers 0.000 claims description 12
- 235000019322 gelatine Nutrition 0.000 claims description 12
- 235000011852 gelatine desserts Nutrition 0.000 claims description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 8
- 125000005456 glyceride group Chemical group 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 235000021466 carotenoid Nutrition 0.000 claims description 7
- 150000001747 carotenoids Chemical class 0.000 claims description 7
- 239000003292 glue Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 5
- 238000010008 shearing Methods 0.000 claims description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 5
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- 235000013871 bee wax Nutrition 0.000 claims description 4
- 239000012166 beeswax Substances 0.000 claims description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 4
- 235000020778 linoleic acid Nutrition 0.000 claims description 4
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 3
- 238000013329 compounding Methods 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 2
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims description 2
- SBJKKFFYIZUCET-JLAZNSOCSA-N Dehydro-L-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(=O)C1=O SBJKKFFYIZUCET-JLAZNSOCSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- -1 diglycerine fatty acid ester Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 235000010352 sodium erythorbate Nutrition 0.000 claims description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 3
- 239000004255 Butylated hydroxyanisole Substances 0.000 claims 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 235000015872 dietary supplement Nutrition 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 230000009469 supplementation Effects 0.000 abstract description 2
- 238000000855 fermentation Methods 0.000 description 76
- 230000004151 fermentation Effects 0.000 description 76
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 71
- 238000001914 filtration Methods 0.000 description 24
- 239000000843 powder Substances 0.000 description 24
- 239000002609 medium Substances 0.000 description 23
- 230000001954 sterilising effect Effects 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 229940041514 candida albicans extract Drugs 0.000 description 16
- 239000012138 yeast extract Substances 0.000 description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
- 239000008103 glucose Substances 0.000 description 15
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 14
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 14
- 241001052560 Thallis Species 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 239000001963 growth medium Substances 0.000 description 14
- 239000004519 grease Substances 0.000 description 12
- 238000001556 precipitation Methods 0.000 description 11
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 238000009874 alkali refining Methods 0.000 description 10
- 238000004332 deodorization Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000000926 separation method Methods 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 9
- 238000002425 crystallisation Methods 0.000 description 9
- 230000008025 crystallization Effects 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- 238000001694 spray drying Methods 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 239000002054 inoculum Substances 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 7
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 7
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 7
- 235000011130 ammonium sulphate Nutrition 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 239000001110 calcium chloride Substances 0.000 description 7
- 229910001628 calcium chloride Inorganic materials 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 235000019341 magnesium sulphate Nutrition 0.000 description 7
- 235000013923 monosodium glutamate Nutrition 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 229940073490 sodium glutamate Drugs 0.000 description 7
- 229910052938 sodium sulfate Inorganic materials 0.000 description 7
- 235000011152 sodium sulphate Nutrition 0.000 description 7
- 108010059892 Cellulase Proteins 0.000 description 6
- 239000001888 Peptone Substances 0.000 description 6
- 108010080698 Peptones Proteins 0.000 description 6
- 241000233671 Schizochytrium Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 229940106157 cellulase Drugs 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 235000019319 peptone Nutrition 0.000 description 6
- 238000007873 sieving Methods 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 239000004365 Protease Substances 0.000 description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 239000010779 crude oil Substances 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 5
- 235000019796 monopotassium phosphate Nutrition 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 5
- 239000001103 potassium chloride Substances 0.000 description 5
- 235000011164 potassium chloride Nutrition 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229940090949 docosahexaenoic acid Drugs 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000003094 microcapsule Substances 0.000 description 3
- 230000003519 ventilatory effect Effects 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- 241000907999 Mortierella alpina Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 235000005770 birds nest Nutrition 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229960001031 glucose Drugs 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000005765 wild carrot Nutrition 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241001191009 Gymnomyza Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000003026 anti-oxygenic effect Effects 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
- A23D9/04—Working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to nutritional supplement and preparation method thereof fields, and in particular to a kind of PUFA soft capsule and preparation method thereof containing sialic acid.Content in the soft capsule includes: the PUFA oil suspension of evenly dispersed sialic acid;The PUFA oil suspension is sialic acid to be added in PUFA oil to be dispersed up to the content for taking oil suspension different parts measurement sialic acid, and the control of content difference obtains within 5%.Soft capsule granule content uniform level provided by the present invention is high, and stability is high, portable and can supplement a variety of nutrition simultaneously, and antioxidant addition is few or does not add, highly-safe, suitable for pregnant baby crowd.The PUFA oil suspension containing sialic acid used in the present invention is conducive to the nutritional supplementation substance of pregnant baby, and prepares easy, material and be easy to get, and moderate cost, product is portable, is easy to save, and is suitable for promoting the use of.
Description
Technical field
The invention belongs to nutritional supplement and preparation method thereof fields, and in particular to a kind of PUFA flexible glue containing sialic acid
Capsule and preparation method thereof.
Background technique
What Chinese invention patent CN104041827 was disclosed is a kind of DHA microcapsules and preparation method thereof containing sialic acid,
Sialic acid extracts gained from bird's nest, and sialic acid is dissolved in water phase, and then prepares the DHA microcapsules containing sialic acid.
There are DHA microcapsule powder, DHA soft capsule and sialic acid powder on the market, but have no the DHA soft capsule containing sialic acid,
This programme can provide a kind of soft capsule of nutritional ingredient diversification.
For pregnant woman, baby can be alleviated because of it by taking the DHA soft capsule containing sialic acid in pregnancy period and the gestational period
Itself sialic acid synthetase and DHA are insufficient and dependent on the sialic acid and DHA in external source food.
Summary of the invention
The present invention provides a kind of PUFA soft capsule and preparation method thereof containing sialic acid.
The PUFA soft capsule containing sialic acid, content include: the PUFA oil suspension of evenly dispersed sialic acid.
The PUFA oil suspension is prepared in the following manner:
Sialic acid is added in PUFA oil, is dispersed up to the content for taking oil suspension different parts measurement sialic acid, it is outstanding by oil
Liquid upper layer and lower layer's sample detection, content difference is within 5%.
The dispersing mode, which uses, first to be sheared, grinds again;
When shearing, 10-35min is carried out under the shear velocity that condition is 10000rpm-20000rpm, preferably condition is
10-20mins is carried out under the shear velocity of 15000rpm-18000rpm.
Condition when grinding are as follows: circular grinding 10- under revolution 1000r/min-4000r/min, 0.2-0.9mm strainer
50min;It preferably, is 2000r/min-3000r/min, the circular grinding 20-30mins under 0.4-0.6mm strainer in revolution.
It is further preferred that carrying out 20min under the shear velocity that condition is 17000rpm when shearing;And/or when grinding
Condition be 2000r/min, strainer 0.4mm, circular grinding 30min.
In the preparation method of PUFA oil suspension of the present invention, it is 98% or more that the sialic acid, which selects sialic acid content,
Saliva acid product;The sialic acid can may be from hydrolysate, the large intestine of natural bird's nest by preparing or being commercially available
The tunning of bacillus, bacillus subtilis tunning.
A kind of preferred method that sialic acid being prepared using Escherichia coli as fermentation thalli is provided herein:
Using Escherichia coli as fermentation thalli, seed liquor is pressed to the inoculum concentration of 1-2%, is added to containing sterilization fermentation culture medium
Fermentor in, the formula of the fermentation medium are as follows: peptone 10-15g/L, yeast extract powder 5-10g/L, sodium chloride 10-
15g/L, pH7.0 ferment under conditions of 37 DEG C, by way of flow feeding, are mended with the rate of 2.5-3g/ (L*h)
Glucose is filled, puts tank after the 70-75h that continuously ferments, obtains the fermentation liquid containing sialic acid, fermented feed liquid divides in such a way that film filters
Bacteria residue is separated out, the liquid being obtained by filtration is obtained using after sterilizing, decoloration, filtering, concentration, crystallization, separation, spray drying, sieving
To sialic acid powder;It is preferred that the Escherichia coli are the Escherichia coli of deposit number CCTCC NO:M 201810.
PUFA oil of the present invention may include this fields such as DHA, ARA, linolenic acid, linoleic acid acceptable activity
The grease of ingredient;Further, including DHA oil or at least one of ARA oil.
Wherein, the DHA oil may come from the produced product of algae, fungi, yeast or fish oil refines product etc. and is rich in
The grease of DHA, it is preferable that content >=35% of DHA in DHA oil;, further preferably algae oil;The DHA oil can pass through preparation
Or commercially available acquisition, it is only necessary to meet above-mentioned DHA content requirement.It will be understood by those skilled in the art that in DHA oil, except DHA at
Exceptionally, there are still the acceptable ingredients in part this field.
Preferred preparation method as DHA oil: using schizochytrium as fermentation thalli, seed liquor is added to and is gone out containing steam
In the fermentor of fermentation medium after bacterium, fermentation substrate includes glucose, yeast extract, sodium glutamate, magnesium ion and calcium
Ion;The ratio 3-5% and dissolved oxygen ratio that the seed liquor and fermentation medium are controlled in fermentation process are less than 10%, 25-
Tank, centrifugation or filtering are put after 28 DEG C of fermentation 100-120h, are collected thallus, are added 0.2% cellulase and 0.2% compound protein
Enzyme carries out breaking-wall cell, is centrifugally separating to obtain DHA crude oil, obtains 22 using degumming, alkali refining, decoloration, precipitation, deodorization etc.
The DHA oil of 40% or more carbon acid content.
Preferably, in parts by weight, the fermentation substrate includes glucose 40-120g/L, yeast extract 4-6g/L, paddy ammonia
Sour sodium 20-40g/L, sodium chloride 1-5g/L, potassium dihydrogen phosphate 1-5g/L, magnesium sulfate 5-10g/L, calcium chloride 0.5-1g/L, carbonic acid
Hydrogen sodium 0.5-1g/L, sodium sulphate 5-10g/L, ammonium sulfate 5-20g/L, potassium chloride 0.5-1g/L, pH are natural.It selects above-mentioned specific
DHA oil, can have the function that collaboration effectively with sialic acid compatibility.
The ARA oil is rich in ARA (eicosatetraenoic acid), to be provided as from the produced product of mortiella Pseudomonas
Preferably, it is further preferred that in ARA oil, content >=40% of ARA;The ARA oil can be by preparation or commercially available acquisition, only
Above-mentioned ARA content requirement need to be met.It will be understood by those skilled in the art that in addition to ARA ingredient, there are still portions in the ARA oil
Divide the acceptable ingredient in this field.
It is further preferred that institute's ARA oil is prepared in the following manner: using Mortierella alpina as fermentation thalli (preferably selection preservation
Number Mortierella alpina for being CCTCC NO:M2013419), fermentation medium after seed liquor is added to containing steam sterilizing
In fermentor, fermentation substrate includes glucose, yeast extract, sodium glutamate, magnesium ion and calcium ion;Kind is controlled in fermentation process
Tank, centrifugation or filtering are put after less than 10%, 28 DEG C fermentation 100h of the ratio 5% and dissolved oxygen ratio of sub- liquid and fermentation medium,
Thallus is collected, 0.2% cellulase is added and 0.2% compound protease carries out breaking-wall cell, is centrifugally separating to obtain ARA maos
Oil, using degumming, alkali refining, decoloration, precipitation, deodorization etc. up to ARA oil.
Preferably, in parts by weight, the fermentation substrate includes glucose 40-120g/L, yeast extract 4-6g/L, paddy ammonia
Sour sodium 20-40g/L, sodium chloride 1-5g/L, potassium dihydrogen phosphate 1-5g/L, magnesium sulfate 5-10g/L, calcium chloride 0.5-1g/L, carbonic acid
Hydrogen sodium 0.5-1g/L, sodium sulphate 5-10g/L, ammonium sulfate 5-20g/L, potassium chloride 0.5-1g/L, pH are natural.
Preferably, seed culture fluid is inoculated into the fermentation flask equipped with fermentation medium after fermented and cultured, further include by
Grade expands culture;
The seed culture medium expanded in incubation step by step are as follows: carbon source 20-50g/l;Nitrogen source 10-20g/l;pH
5.5-8.5, and bacterium is dense reach 15-30% (volumetric concentration) when carry out in next step expand culture;Every grade of incubation time is 24-
50h, cultivation temperature are 25-30 DEG C, and ventilatory capacity is required air per minute in 1-2vvm (L/L.min) i.e. every liter of fermentation liquid
Intake is 1-2L, and tank presses 0.05-0.15MPa, and mixing speed is that 150-300 turns/min;Then the seed of above-mentioned acquisition is expanded
Big culture solution, which is inoculated into final fermentor, carries out fermented and cultured, inoculum concentration 10-20% (volume ratio), fermentation jar temperature 25-30
DEG C, 200-300 revs/min of mixing speed, in every liter of fermentation liquid of ventilatory capacity 1-2vvm (L/L.min) i.e. per minute required for it is empty
Gas intake is 1-2L, and tank presses 0.05-0.15Mpa, cultivates 150-180h, and control during the fermentation by stream plus carbon source
Fermentation medium of the carbon source concentration in 5-20g/L, the fermentor in fermentation liquid are as follows: carbon source 30-50g/l;Nitrogen source 10-20g/
l;pH5.5-8.5.Degumming, alkali refining, decoloration, precipitation, deodorization etc. obtain 40% or more Eicosatetraenoic acid content again after broken wall
The grease of ARA.
Preferably, also can further include can receive containing this fields such as linolenic acid, linoleic acid in the PUFA oil
Active constituent grease;Other PUFA oil such as linolenic acid, linoleic acid may be from this fields such as linseed oil, sunflower oil can
Other PUFA oil received.
Preferably, in PUFA oil, the content ratio of DHA oil and ARA oil is (2-3): 1, and DHA oil and oily total of ARA
Content accounts at least the 80% of the PUFA oil.
In the preparation method of PUFA oil suspension of the present invention, it is preferable that when shearing, condition is the shearing of 17000rpm
20mins is carried out under speed.
In the preparation method of PUFA oil suspension of the present invention, it is preferable that condition when grinding is 2000r/min, filter
Net is 0.4mm, circular grinding 30mins.
In the preparation method of PUFA oil suspension of the present invention, it is preferable that the mass ratio of the sialic acid and PUFA oil
For 1:(1.5-10), preferably 1: (4-8).
In the preparation method of PUFA oil suspension of the present invention, obtained oil suspension partial size is≤34 μm, it is further excellent
Selection of land, the partial size of oil suspension are≤25.5 μm.
PUFA soft capsule of the present invention containing sialic acid, content further include dilution, suspending liquid, antioxidant
One or more of.
The dilution is selected from one or more of polyethylene glycol, propylene glycol, single diglycerine fatty acid ester, vegetable oil,
Wherein vegetable oil may include one or more of compoundings such as peanut oil, soybean oil, rapeseed oil;It is preferred that polyethylene glycol and propylene glycol.
It is more preferable using the compatibility of polyethylene glycol and propylene glycol as dilution and PUFA, and being capable of suspending SA particle to a certain extent.
It is sweet that the suspending liquid is selected from rosin glycerides, phosphatide, medium chain triglyceride, beeswax, sapn, tween, monostearate
One or more compoundings in grease, bi-tristearin;It is preferred that one of medium chain triglyceride, beeswax, sapn and phosphatide
Or two kinds.These types is good in oil compatibility, can not only play stabilization and can also adjust density of matrix and reach and preferably hold
Carry effect.The suspending liquid is added directly into dispersing and dissolving in oil matrix.
The antioxidant is selected from ascorbic acid and its salt, arabo-ascorbic acid and its salt, ascorbic acid palm ester, vitamin
E, one or more of 2,6 di tert butyl 4 methyl phenol (BHT), butylated hydroxy anisole (BHA);
In the PUFA soft capsule, using polyethylene glycol as dilution, phosphatide is suspending liquid, ascorbyl palmitate
When as antioxidant, the synergistic effect of above-mentioned auxiliary agent can be utilized, the stability and inoxidizability of whole system are obviously improved.
As the preferred technical solution of the present invention, a kind of PUFA soft capsule containing sialic acid is provided, in parts by weight,
It is grouped as by following group:
80-100 parts of the PUFA oil suspension of the evenly dispersed sialic acid, 0-25 parts of dilution, 1-15 parts of suspending liquid, antioxygen
0-5 parts of agent;
It is highly preferred that
80-90 parts of the PUFA oil suspension of the evenly dispersed sialic acid, 3-15 parts of dilution, 1-15 parts of suspending liquid, antioxygen
0-0.8 parts of agent.
It is further preferred that the dilution is the 3.3-18.7wt% of the PUFA oil suspension;
And/or the suspending liquid is the 1.1-18.75wt% of the PUFA oil suspension;
And/or when the antioxidant PUFA oil suspension 0-1wt%.
Under normal circumstances, the additive amount of antioxidant is but provided by the present invention 1% or so in common PUFA grease
In formula, since the overall coordination of active constituent, diluent and suspending liquid acts on, antioxidant can not be added, or few
Amount addition.
In PUFA soft capsule of the present invention containing sialic acid, the active constituent of the PUFA oil suspension includes quality
Than the sialic acid and PUFA for 1:(1.5-20) (mass ratio is with 1: (4-8) is more excellent);
The active constituent can also further comprise carotenoid;The content of the carotenoid is no more than described
The 20% of PUFA oil parts by weight;The more preferable carotenoid is bata-carotene, and bata-carotene is good compatible with oily phase
Property and antioxygenic property, enable to system more stable.
As the highly preferred technical solution of the present invention, the PUFA soft capsule containing sialic acid, content include (by
Following group is grouped as):
80-85 parts of PUFA oil suspension;4.5-15 parts of polyethylene glycol;0-2 parts of sapn, medium-chain fatty glyceride (MCT) 2-
15 parts.
It include sialic acid, DHA oil, ARA oil, carotenoid in the PUFA oil suspension.
The present invention provides the preparation method of soft capsule described in above-mentioned any one technical solution together, and steps are as follows:
Through pelleting by the content and utricule to obtain the final product.
The utricule is prepared or commercially available using the acceptable preparation method in this field;
There is provided a kind of more preferred preparation method herein: the utricule is former using gelatin, glycerol and pure water as utricule
What material was prepared;
Specifically, by glycerol and pure water injection glue pot, it is heated with stirring to 60-80 DEG C, adds gelatin, continues to stir
Vacuum demoulds after 20-30 minutes, and utricule is prepared.
It will be understood by those skilled in the art that above-mentioned preparation process may also include this field and prepare capsule in addition to pelleting
Technological means, such as be formed, wash ball, drying, pick ball and packing step.
Soft capsule granule content uniform level provided by the present invention is high, and stability is high, portable and can supplement simultaneously more
Kind nutrition, antioxidant addition is few or does not add, highly-safe, is suitable for pregnant baby crowd.Contain described in used in the present invention
There is the PUFA oil suspension of sialic acid to be conducive to the nutritional supplementation substance of pregnant baby, and prepare easy, material and be easy to get, moderate cost produces
Product are portable, are easy to save, and are suitable for promoting the use of.
Specific embodiment
The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention..
Embodiment 1
The present embodiment provides a kind of PUFA oil suspension and preparation method thereof containing sialic acid, the PUFA oil are DHA oil;
Specific step is as follows:
1) sialic acid powder 20g is taken, is mixed with the DHA oil of 160g, is sheared under the conditions of 17000rpm to abundant point
It dissipates;
The different parts of oil suspension are taken to be measured after dispersion, the difference of sialic acid content is less than 3%;
2) sialic acid and DHA oil mixture after taking step 1) to disperse carry out high speed grinding, under nitrogen filled protection, with
The speed of 2000r/min, sieve gap 0.4mm, the grinding 30mins time to obtain the final product.
Sialic acid powder described in the present embodiment, DHA oil derive from commercially available;Sialic acid content in the sialic acid powder
Content >=35% of DHA during > 98%, the DHA are oily.
Embodiment 2
The present embodiment provides a kind of PUFA oil suspension and preparation method thereof containing sialic acid, the PUFA oil are DHA oil;
Difference with embodiment 1 is only that:
Sialic acid powder employed in the present embodiment is prepared by the following method:
Using Escherichia coli as fermentation thalli, seed liquor is pressed 1% inoculum concentration by deposit number CCTCC NO:M 201810,
It is added in the fermentor containing sterilization fermentation culture medium, LB culture medium contains: peptone 10g/L, yeast extract powder 5g/L, chlorine
Change sodium 10g/L, pH7.0, ferment under conditions of 37 DEG C, by way of flow feeding, is carried out with the rate of 2.5g/ (L*h)
Glucose is supplemented, puts tank after the 75h that continuously ferments, obtains the fermentation liquid containing sialic acid, fermented feed liquid divides in such a way that film filters
Bacteria residue is separated out, the liquid being obtained by filtration is obtained using after sterilizing, decoloration, filtering, concentration, crystallization, separation, spray drying, sieving
To sialic acid powder.
Sterilizing, decoloration, filtering, concentration, crystallization, separation, spray drying in above step and etc. according to this field
Usual manner operation.
DHA oil described in the present embodiment is from commercially available;Content >=35% of DHA in the DHA oil.
Embodiment 3
The present embodiment provides a kind of PUFA oil suspension and preparation method thereof containing sialic acid, the PUFA oil are DHA oil;
Difference with embodiment 2 is only that:
DHA oil employed in the present embodiment is prepared by the following method:
Using schizochytrium as fermentation thalli, the fermentor of the fermentation medium after seed liquor is added to containing steam sterilizing
In, the formula of fermentation medium is as follows: glucose 100g/L, yeast extract 6g/L, sodium glutamate 20g/L, sodium chloride 3g/L, phosphorus
Acid dihydride potassium 2g/L, magnesium sulfate 5g/L, calcium chloride 1g/L, sodium bicarbonate 0.5g/L, sodium sulphate 7g/L, ammonium sulfate 8g/L, chlorination
Potassium 0.6g/L, pH are natural;The ratio 5% and dissolved oxygen ratio that seed liquor and fermentation medium are controlled in fermentation process are 8%, 28
Tank is put after DEG C fermentation 100h, and thallus is collected in centrifugation or filtering, adds 0.1% cellulase and 0.2% compound protease carries out
Breaking-wall cell is centrifugally separating to obtain DHA crude oil, obtains two dodecahexaenes using degumming, alkali refining, decoloration, precipitation, deodorization etc.
The grease of the DHA of 40% or more acid content.
Degumming described in above step, alkali refining, decoloration, precipitation, deodorization and etc. be all made of this field routine fermentation,
Lock out operation.
Embodiment 4
The present embodiment provides a kind of PUFA oil suspension and preparation method thereof containing sialic acid, the PUFA oil are DHA oil;
Specific step is as follows:
1) sialic acid is prepared:
Using Escherichia coli as fermentation thalli, seed liquor is pressed 1% inoculum concentration by deposit number CCTCC NO:M 201810,
It is added in the fermentor containing sterilization fermentation culture medium, LB culture medium contains: peptone 10g/L, yeast extract powder 5g/L, chlorine
Change sodium 10g/L, pH7.0, ferment under conditions of 37 DEG C, by way of flow feeding, is carried out with the rate of 2.5g/ (L*h)
Glucose is supplemented, puts tank after the 75h that continuously ferments, obtains the fermentation liquid containing sialic acid, fermented feed liquid divides in such a way that film filters
Bacteria residue is separated out, the liquid being obtained by filtration is obtained using after sterilizing, decoloration, filtering, concentration, crystallization, separation, spray drying, sieving
To sialic acid powder.
Sterilizing, decoloration, filtering, concentration, crystallization, separation, spray drying in above step and etc. according to this field
Usual manner operation.
2) preparation DHA oil:
Using schizochytrium as fermentation thalli, the fermentor of the fermentation medium after seed liquor is added to containing steam sterilizing
In, the formula of fermentation medium is as follows: glucose 100g/L, yeast extract 6g/L, sodium glutamate 20g/L, sodium chloride 3g/L, phosphorus
Acid dihydride potassium 2g/L, magnesium sulfate 5g/L, calcium chloride 1g/L, sodium bicarbonate 0.5g/L, sodium sulphate 7g/L, ammonium sulfate 8g/L, chlorination
Potassium 0.6g/L, pH are natural;The ratio 5% and dissolved oxygen ratio that seed liquor and fermentation medium are controlled in fermentation process are 8%, 28
Tank is put after DEG C fermentation 100h, and thallus is collected in centrifugation or filtering, adds 0.1% cellulase and 0.2% compound protease carries out
Breaking-wall cell is centrifugally separating to obtain DHA crude oil, obtains two dodecahexaenes using degumming, alkali refining, decoloration, precipitation, deodorization etc.
The grease of the DHA of 40% or more acid content.
3) the DHA oil of the sialic acid powder 20g for taking step 1) to be prepared, the 100g being prepared with step 2) mix,
It is sheared under the conditions of 17000rpm to fully dispersed;
4) sialic acid and DHA oil mixture after taking step 3) to disperse carry out high speed grinding, under nitrogen filled protection, with
The speed of 2000r/min, sieve gap 0.4mm, the grinding 30mins time to obtain the final product.
Degumming described in above step, alkali refining, decoloration, precipitation, deodorization and etc. be all made of this field routine fermentation,
Lock out operation.
Embodiment 5
The present embodiment provides a kind of PUFA oil suspension and preparation method thereof containing sialic acid, the PUFA oil are DHA oil;
Specific step is as follows:
1) sialic acid is prepared:
Using Escherichia coli as fermentation thalli, seed liquor is pressed 1% inoculum concentration by deposit number CCTCC NO:M 201810,
It is added in the fermentor containing sterilization fermentation culture medium, LB culture medium contains: peptone 10g/L, yeast extract powder 5g/L, chlorine
Change sodium 10g/L, pH7.0, ferment under conditions of 37 DEG C, by way of flow feeding, is carried out with the rate of 2.5g/ (L*h)
Glucose is supplemented, puts tank after the 75h that continuously ferments, obtains the fermentation liquid containing sialic acid, fermented feed liquid divides in such a way that film filters
Bacteria residue is separated out, the liquid being obtained by filtration is obtained using after sterilizing, decoloration, filtering, concentration, crystallization, separation, spray drying, sieving
To sialic acid powder.
Sterilizing, decoloration, filtering, concentration, crystallization, separation, spray drying in above step and etc. according to this field
Usual manner operation.
2) preparation DHA oil:
Using schizochytrium as fermentation thalli, the fermentor of the fermentation medium after seed liquor is added to containing steam sterilizing
In, glucose 100g/L, yeast extract 6g/L, sodium glutamate 20g/L, sodium chloride 3g/L, potassium dihydrogen phosphate 2g/L, magnesium sulfate
5g/L, calcium chloride 1g/L, sodium bicarbonate 0.5g/L, sodium sulphate 7g/L, ammonium sulfate 8g/L, potassium chloride 0.6g/L, pH are natural;Fermentation
The ratio 5% and dissolved oxygen ratio for controlling seed liquor and fermentation medium in the process are 8%, put tank after 28 DEG C of fermentation 100h, from
Thallus is collected in the heart or filtering, adds 0.1% cellulase and 0.2% compound protease carries out breaking-wall cell, is centrifugated
To DHA crude oil, the DHA of 40% or more docosahexaenoic acid content is obtained using degumming, alkali refining, decoloration, precipitation, deodorization etc.
Grease.
3) the DHA oil of the sialic acid powder 40g for taking step 1) to be prepared, the 160g being prepared with step 2) mix,
It is sheared under the conditions of 18000rpm to fully dispersed;
4) sialic acid and DHA oil mixture after taking step 3) to disperse carry out high speed grinding, under nitrogen filled protection, with
The speed of 2500r/min, sieve gap 0.35mm, the grinding 25mins time to obtain the final product.
Degumming described in above step, alkali refining, decoloration, precipitation, deodorization and etc. be all made of this field routine fermentation,
Lock out operation.
Embodiment 6
The present embodiment provides a kind of PUFA oil suspension and preparation method thereof containing sialic acid, the PUFA oil are DHA oil;
Specific step is as follows:
1) sialic acid is prepared:
Using Escherichia coli as fermentation thalli, seed liquor is pressed 1% inoculum concentration by deposit number CCTCC NO:M 201810,
It is added in the fermentor containing sterilization fermentation culture medium, LB culture medium contains: peptone 10g/L, yeast extract powder 5g/L, chlorine
Change sodium 10g/L, pH7.0, ferment under conditions of 37 DEG C, by way of flow feeding, is carried out with the rate of 2.5g/ (L*h)
Glucose is supplemented, puts tank after the 75h that continuously ferments, obtains the fermentation liquid containing sialic acid, fermented feed liquid divides in such a way that film filters
Bacteria residue is separated out, the liquid being obtained by filtration is obtained using after sterilizing, decoloration, filtering, concentration, crystallization, separation, spray drying, sieving
To sialic acid powder.
2) preparation DHA oil:
Using schizochytrium as fermentation thalli, the fermentor of the fermentation medium after seed liquor is added to containing steam sterilizing
In, glucose 100g/L, yeast extract 6g/L, sodium glutamate 20g/L, sodium chloride 3g/L, potassium dihydrogen phosphate 2g/L, magnesium sulfate
5g/L, calcium chloride 1g/L, sodium bicarbonate 0.5g/L, sodium sulphate 7g/L, ammonium sulfate 8g/L, potassium chloride 0.6g/L, pH are natural;Fermentation
The ratio 5% and dissolved oxygen ratio for controlling seed liquor and fermentation medium in the process are 8%, put tank after 28 DEG C of fermentation 100h, from
Thallus is collected in the heart or filtering, adds 0.1% cellulase and 0.2% compound protease carries out breaking-wall cell, is centrifugated
To DHA crude oil, the DHA of 40% or more docosahexaenoic acid content is obtained using degumming, alkali refining, decoloration, precipitation, deodorization etc.
Grease.
3) the DHA oil of the sialic acid powder 40g for taking step 1) to be prepared, the 80g being prepared with step 2) mix,
It is sheared under the conditions of 18000rpm to fully dispersed;
4) sialic acid and DHA oil mixture after taking step 3) to disperse carry out high speed grinding, under nitrogen filled protection, with
The speed of 2500r/min, sieve gap 0.35mm, the grinding 30mins time to obtain the final product.
Embodiment 7
The present embodiment provides a kind of PUFA oil suspension and preparation method thereof containing sialic acid, the PUFA oil are DHA oil
With the miscella of ARA oil;Specific step is as follows:
1) sialic acid is prepared:
Using Escherichia coli as fermentation thalli, seed liquor is pressed 1% inoculum concentration by deposit number CCTCC NO:M 201810,
It is added in the fermentor containing sterilization fermentation culture medium, LB culture medium contains: peptone 10g/L, yeast extract powder 5g/L, chlorine
Change sodium 10g/L, pH7.0, ferment under conditions of 37 DEG C, by way of flow feeding, is carried out with the rate of 2.5g/ (L*h)
Glucose is supplemented, puts tank after the 75h that continuously ferments, obtains the fermentation liquid containing sialic acid, fermented feed liquid divides in such a way that film filters
Bacteria residue is separated out, the liquid being obtained by filtration is obtained using after sterilizing, decoloration, filtering, concentration, crystallization, separation, spray drying, sieving
To sialic acid powder.
2) preparation DHA oil:
Using schizochytrium as fermentation thalli, the fermentor of the fermentation medium after seed liquor is added to containing steam sterilizing
In, the formula of the fermentation medium is as follows: glucose 100g/L, yeast extract 6g/L, sodium glutamate 20g/L, sodium chloride 3g/
L, potassium dihydrogen phosphate 2g/L, magnesium sulfate 5g/L, calcium chloride 1g/L, sodium bicarbonate 0.5g/L, sodium sulphate 7g/L, ammonium sulfate 8g/L,
Potassium chloride 0.6g/L, pH are natural;Seed liquor is controlled in fermentation process and the ratio 5% and dissolved oxygen ratio of fermentation medium are
Tank, centrifugation or filtering are put after 8%, 28 DEG C of fermentation 100h, collects thallus, adjust pH value to 11.5,0.1%g basic protein is added
Enzyme, 10% phosphatide, digest 5h by 40 DEG C of temperature control, and film is added in the mixture after the mixture, cell cracking after obtaining cell cracking
Filter plant, circulating filtration isolate the emulsified fat containing moisture;
The sodium chloride of 3.0% missible oil weight is added into the emulsified fat containing moisture, sedimentation takes supernatant after stirring and evenly mixing
Liquid obtains the grease of the DHA of 40% or more docosahexaenoic acid content.3) preparation ARA oil
After the bacterium in 50m3 seeding tank is dense reach 30% (volume ratio) after, be linked by culture transferring pipeline equipped with 130m3Hair
The 200m of ferment culture medium3It is cultivated in fermentor, inoculum concentration 20% (volume ratio), fermentor controls 30 DEG C of temperature, stirring speed
300 revs/min, ventilatory capacity 1.5vvm (L/L.min) of degree, tank press 0.15Mpa, cultivate 180h.Pass through stream plus carbon in fermentation process
Source controls in fermentation liquid carbon source concentration in 20g/L, the fermentation tank culture medium are as follows: carbon source starch 50g/l;Nitrogen source yeast extract
20g/l;pH 8.5.The separation of fermentative broth that fermented and cultured obtains, obtains wet thallus, and drying obtains dry mycelium 50g.Into dry mycelium
Extractant n-hexane is added to be extracted, isolated solid formation, which is transferred in extraction container, after extraction carries out repeating extraction, such as
This, terminates extraction process, 200 milliliters of n-hexanes is added when extracting for the first time, be added every time later when until oil-free in extract liquor
150 milliliters of n-hexanes, the miscella being separated by filtration after each extraction is filled, precipitation obtain ARA grease.
4) the DHA oil and step of the sialic acid powder 30g, the 160g being prepared with step 2) that take step 1) to be prepared
3) the 80gARA mixing being made, is sheared under the conditions of 18000rpm to fully dispersed;
5) sialic acid and DHA/ARA oil mixture after taking step 4) to disperse carry out high speed grinding, under nitrogen filled protection, with
The speed of 2500r/min, sieve gap 0.35mm, the grinding 30mins time to obtain the final product.
Embodiment 8
The source of SA and DHA and preparation method be with embodiment 3 in the present embodiment oil suspension, the difference is that, in step 3
Before added with 10% beta carotene for accounting for the PUFA oil gross mass, added during step 3.
Embodiment 9
The source of SA, DHA and ARA and preparation method be with embodiment 7 in the present embodiment oil suspension, the difference is that,
It is added with 1.7% beta carotene before step 3, is added during step 3, and sialic acid powder is 20g, DHA+
ARA oil is 80g.
After oil suspension obtained by above-described embodiment 1-9 is prepared is placed for 24 hours, through the sialic acid content for measuring variant position
Difference is below 5%.
Embodiment 10
The present embodiment provides a kind of PUFA soft capsule containing sialic acid, content include:
Embodiment 11
The present embodiment provides a kind of PUFA soft capsule containing sialic acid, content include:
Embodiment 12
The present embodiment provides a kind of PUFA soft capsule containing sialic acid, content include:
Embodiment 13
The present embodiment provides a kind of PUFA soft capsule containing sialic acid, content include:
Embodiment 14
The present embodiment provides a kind of PUFA soft capsule containing sialic acid, content include:
Embodiment 15
The present embodiment provides a kind of PUFA soft capsule containing sialic acid, content include:
PUFA oil suspension provides 85 parts by embodiment 9;
15 parts of dilution propylene glycol.
Embodiment 16
The present embodiment provides a kind of PUFA soft capsules and preparation method thereof, specifically, include the following steps:
1. 10 parts of 82.5 parts of the PUFA oil suspension and dilution polyethylene glycol of the evenly dispersed sialic acid of Example 3,
5 parts of 2 parts+medium-chain fatty glyceride of suspending liquid sapn, E0.5 parts of antioxidant vitamin be content;
2. preparing utricule: using gelatin, glycerol and pure water as utricule raw material, by glycerol and pure water injection glue pot, stirring
It mixes and is heated to 60-80 DEG C, add gelatin, vacuum demoulds after continuing stirring 20-30 minutes, and utricule is prepared;
3. preparing capsule: by content prepared by step 1 and utricule prepared by step 2 by pelleting, be formed, wash ball, dry
It is dry, pick ball and packing step, PUFA soft capsule is prepared.
Embodiment 17
The present embodiment provides a kind of PUFA soft capsules and preparation method thereof, specifically, include the following steps:
1. preparing content: evenly dispersed 84.5 parts of the PUFA oil suspension and polyethylene glycol of sialic acid of Example 7
10 parts, 5 parts of medium chain triglyceride, 0.5 part of vitamin E be content;
2. preparing utricule: using 10 parts of gelatin, 3 parts of glycerol and 10 parts of pure water as utricule raw material, glycerol and pure water being injected
In glue pot, it is heated with stirring to 60-80 DEG C, adds gelatin, vacuum demoulds after continuing stirring 20-30 minutes, and capsule is prepared
Body;
3. preparing capsule: by content prepared by step 1 and utricule prepared by step 2 by pelleting, be formed, wash ball, dry
It is dry, pick ball and packing step, PUFA soft capsule is prepared.
Embodiment 18
The present embodiment provides a kind of PUFA soft capsules and preparation method thereof, specifically, include the following steps:
1. preparing content: evenly dispersed 85 parts of the PUFA oil suspension and polyethylene glycol 8 of sialic acid of Example 7
Part, 5 parts of 2 parts+medium-chain fatty glyceride of sapn (MCT) be content;
2. preparing utricule: using 10 parts of gelatin, 3 parts of glycerol and 10 parts of pure water as utricule raw material, glycerol and pure water being injected
In glue pot, it is heated with stirring to 60-80 DEG C, adds gelatin, vacuum demoulds after continuing stirring 20-30 minutes, and capsule is prepared
Body;
3. preparing capsule: by content prepared by step 1 and utricule prepared by step 2 by pelleting, be formed, wash ball, dry
It is dry, pick ball and packing step, PUFA soft capsule is prepared.
Embodiment 19
The present embodiment provides PUFA soft capsules and preparation method thereof described in embodiment 14 specifically to include the following steps:
1. preparing content: evenly dispersed 85 parts of the PUFA oil suspension and polyethylene glycol 4.5 of sialic acid of Example 9
Part, 10 parts of medium-chain fatty glyceride (MCT), 0.5 part of ascorbyl palmitate be content;
2. preparing utricule: using 10 parts of gelatin, 3 parts of glycerol and 10 parts of pure water as utricule raw material, glycerol and pure water being injected
In glue pot, it is heated with stirring to 60-80 DEG C, adds gelatin, vacuum demoulds after continuing stirring 20-30 minutes, and capsule is prepared
Body;
3. preparing capsule: by content prepared by step 1 and utricule prepared by step 2 by pelleting, be formed, wash ball, dry
It is dry, pick ball and packing step, PUFA soft capsule is prepared.
Comparative example 1
This comparative example provides a kind of DHA oil suspension and preparation method thereof containing sialic acid, compared with Example 1 compared with area
It is not only that, sialic acid powder usage amount is 80g, and DHA oil usage amount is 40g.
Comparative example 2
This comparative example provides a kind of DHA oil suspension and preparation method thereof containing sialic acid, compared with Example 1 compared with area
It is not only that, step 2) is replaced with is dispersed using ultrasonic power, ultrasound condition 25kHz, is carried out 20 minutes.
Comparative example 3
This comparative example provides a kind of PUFA soft capsule containing sialic acid, and content includes:
Comparative example 4
This comparative example provides a kind of PUFA soft capsule containing sialic acid, and content includes:
Comparative example 5
This comparative example provides a kind of PUFA soft capsule containing sialic acid, and content includes:
Comparative example 6
This comparative example provides a kind of PUFA soft capsule, and content includes:
Test example 1
This test example provides the stability test of soft capsule provided by embodiment 8-13, includes hot test, Qiang Guangshi
It tests and long term test.
1, capsule quality is examined
1.1 are detected 9-14 of the embodiment of the present invention and comparative example 3-5 soft capsule prepared by emphasis quality index, point
Its quality change situation is not investigated, and content and related substance are detected with methanol: water (3: 1) is mobile phase, and Detection wavelength is
240nm is checked with efficient form and aspect chromatography.
1.2 the results are shown in Table 1.
1 capsule quality of table detects (every 100)
2, long-term stable experiment
2.1 soft capsules for preparing 9-14 of the embodiment of the present invention and comparative example 3-6 are at 25 DEG C ± 2 DEG C of temperature, relative humidity
It places under the conditions of 60% ± 10%, respectively at the 3rd, inspection by sampling in 6 months, is detected by emphasis quality index for a long time, respectively
Its quality change situation is investigated,
2.2 the results are shown in Table 2.
2 long-term stable experiment result of table
Table 2 the results show that the soft capsule sample of 8-14 of embodiment of the present invention preparation through 25 DEG C ± 2 DEG C of temperature, relative humidity
It is placed for a long time 6 months under the conditions of 60% ± 10%, compared with 0 day, every quality index variation is less, relatively stable.
Although above having used general explanation, specific embodiment and test, the present invention is made to retouch in detail
It states, but on the basis of the present invention, it can be made some modifications or improvements, this is apparent to those skilled in the art
's.Therefore, these modifications or improvements without departing from theon the basis of the spirit of the present invention, belong to claimed
Range.
Claims (10)
1. a kind of PUFA soft capsule containing sialic acid, which is characterized in that content includes: the PUFA oil of evenly dispersed sialic acid
Suspension.
2. soft capsule according to claim 1, which is characterized in that the PUFA oil suspension is that sialic acid is added to PUFA oil
In be dispersed up to take oil suspension different parts measurement sialic acid content, content difference control within 5% to obtain the final product;
Preferably, the PUFA oil suspension of the evenly dispersed sialic acid is prepared by following methods:
The dispersing mode, which uses, first to be sheared, grinds again;
When shearing, 10-35min is carried out under the shear velocity that condition is 10000rpm-20000rpm, it is highly preferred that condition is
10-20mins is carried out under the shear velocity of 15000rpm-18000rpm;
Condition when grinding are as follows: circular grinding 10-50min under revolution 1000r/min-4000r/min, 0.2-0.9mm strainer;
It is highly preferred that being 2000r/min-3000r/min, the circular grinding 20-30mins under 0.4-0.6mm strainer in revolution.
3. PUFA soft capsule according to claim 1 or 2, which is characterized in that the content further includes dilution, suspending
One or more of liquid, antioxidant;
Preferably, the PUFA soft capsule is in parts by weight, comprising:
80-100 parts of the PUFA oil suspension of the evenly dispersed sialic acid, 0-25 parts of dilution, 1-15 parts of suspending liquid, antioxidant
0-5 parts;
It is highly preferred that
80-90 parts of the PUFA oil suspension of the evenly dispersed sialic acid, 3-15 parts of dilution, 1-15 parts of suspending liquid, antioxidant
0-0.8 parts.
4. PUFA soft capsule according to claim 3, which is characterized in that in the content, the dilution is selected from poly-
One or more of ethylene glycol, propylene glycol, single diglycerine fatty acid ester, vegetable oil;It is preferred that polyethylene glycol and/or propylene glycol;
And/or the suspending liquid is selected from rosin glycerides, phosphatide, medium chain triglyceride, beeswax, sapn, tween, monostearate
One or more compoundings in glyceride, bi-tristearin;It is preferred that one in medium chain triglyceride, beeswax, sapn and phosphatide
Kind or two kinds;
And/or the antioxidant is selected from ascorbic acid and its salt, arabo-ascorbic acid and its salt, ascorbic acid palm ester, dimension life
One or more of plain E, 2,6 di tert butyl 4 methyl phenol, butylated hydroxy anisole.
5. PUFA soft capsule according to claim 3 or 4, which is characterized in that the dilution is the PUFA oil suspension
3.3-18.7wt%;
And/or the suspending liquid is the 1.1-18.75wt% of the PUFA oil suspension;
And/or when the antioxidant PUFA oil suspension 0-1wt%.
6. PUFA soft capsule according to claim 1-5, which is characterized in that the evenly dispersed sialic acid
PUFA oil suspension includes that mass ratio is oily for the sialic acid and PUFA of 1:(1.5-20);It is preferred that 1: (4-8).
7. PUFA soft capsule according to claim 1-6, which is characterized in that the evenly dispersed sialic acid
In PUFA oil suspension, the PUFA oil includes at least one of DHA, ARA, linolenic acid, linoleic acid;
Preferably, the PUFA oil includes at least one of DHA oil or ARA oil;
It is highly preferred that the content ratio of the DHA oil and ARA oil is (2- in the PUFA oil suspension of the evenly dispersed sialic acid
3): 1, and the total content of DHA oil and ARA oil accounts at least the 80% of the PUFA oil.
8. PUFA soft capsule according to claim 7, which is characterized in that the PUFA oil suspension of the evenly dispersed sialic acid
In further include carotenoid;
Preferably, the content of the carotenoid is no more than the 20% of the PUFA oil parts by weight.
9. PUFA soft capsule according to claim 1-8, which is characterized in that in parts by weight, comprising: PUFA
80-85 parts of oil suspension;4.5-15 parts of polyethylene glycol;0-2 parts of sapn, 2-15 parts of medium-chain fatty glyceride;
It include sialic acid, DHA oil, ARA oil, carotenoid in the PUFA oil suspension.
10. a kind of method for preparing the described in any item PUFA soft capsules of claim 1-9, which is characterized in that by the content
Object and utricule through pelleting to obtain the final product;
Preferably, the utricule is prepared using gelatin, glycerol and pure water as utricule raw material;Glycerol and pure water are injected
In glue pot, it is heated with stirring to 60-80 DEG C, adds gelatin, vacuum demoulds after continuing stirring 20-30 minutes, and capsule is prepared
Body.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811358736.0A CN109601980A (en) | 2018-11-15 | 2018-11-15 | A kind of PUFA soft capsule and preparation method thereof containing sialic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811358736.0A CN109601980A (en) | 2018-11-15 | 2018-11-15 | A kind of PUFA soft capsule and preparation method thereof containing sialic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109601980A true CN109601980A (en) | 2019-04-12 |
Family
ID=66004070
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811358736.0A Pending CN109601980A (en) | 2018-11-15 | 2018-11-15 | A kind of PUFA soft capsule and preparation method thereof containing sialic acid |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109601980A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110547456A (en) * | 2019-09-02 | 2019-12-10 | 嘉必优生物技术(武汉)股份有限公司 | carotenoid microcapsule taking sialic acid as coating material and preparation method and application thereof |
CN112493477A (en) * | 2020-11-30 | 2021-03-16 | 嘉必优生物技术(武汉)股份有限公司 | Use of a sialylated oil suspension for the preparation of capsules |
CN112535292A (en) * | 2020-11-30 | 2021-03-23 | 嘉必优生物技术(武汉)股份有限公司 | Sialic acid oil suspension, and preparation method and application thereof |
CN118147023A (en) * | 2024-05-13 | 2024-06-07 | 山东润德生物科技有限公司 | Composite starter and application thereof in preparation of N-acetylneuraminic acid |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10327804A (en) * | 1997-06-04 | 1998-12-15 | Meiji Milk Prod Co Ltd | Nucleic acid-relating substance, dha, arachidonic acid and composition |
CN1701789A (en) * | 2005-05-13 | 2005-11-30 | 韩孝清 | Nutrition replenisher containing sialic acid and its derivative |
CN1842277A (en) * | 2003-06-24 | 2006-10-04 | 堪萨斯大学医学中心 | Infant formula |
CN102965182A (en) * | 2012-11-27 | 2013-03-13 | 新奥科技发展有限公司 | Method for extracting grease from schizochytrium |
CN103238670A (en) * | 2013-05-14 | 2013-08-14 | 吉林大学 | Milk tablet containing sialic acid and preparation method thereof |
CN104041827A (en) * | 2014-06-30 | 2014-09-17 | 江苏布诺堂健康生物科技有限公司 | Microcapsule containing sialic acid and DHA and preparation method thereof |
CN104046671A (en) * | 2014-06-24 | 2014-09-17 | 东北农业大学 | Fermentation production method of sialic acid |
CN107467667A (en) * | 2017-07-17 | 2017-12-15 | 北京亦贝安生物医药科技有限公司 | A kind of compound preparation containing two kinds of unrighted acids and sialic acid |
CN107712050A (en) * | 2017-09-15 | 2018-02-23 | 安徽科技学院 | One kind addition sialic acid and digestible premature labor baby milk powder and preparation method thereof |
CN108354174A (en) * | 2018-05-25 | 2018-08-03 | 云南众爱生物科技有限公司 | A kind of Sialic acid soft capsule and preparation method thereof |
CN108486178A (en) * | 2018-02-27 | 2018-09-04 | 广州富诺健康科技股份有限公司 | A kind of preparation method of algae oil DHA |
CN108570484A (en) * | 2017-03-07 | 2018-09-25 | 武汉普赛特膜技术循环利用有限公司 | A method of using fermentation method three times by purification enrichment DHA grease in algae zymotic fluid |
-
2018
- 2018-11-15 CN CN201811358736.0A patent/CN109601980A/en active Pending
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10327804A (en) * | 1997-06-04 | 1998-12-15 | Meiji Milk Prod Co Ltd | Nucleic acid-relating substance, dha, arachidonic acid and composition |
CN1842277A (en) * | 2003-06-24 | 2006-10-04 | 堪萨斯大学医学中心 | Infant formula |
CN1701789A (en) * | 2005-05-13 | 2005-11-30 | 韩孝清 | Nutrition replenisher containing sialic acid and its derivative |
CN102965182A (en) * | 2012-11-27 | 2013-03-13 | 新奥科技发展有限公司 | Method for extracting grease from schizochytrium |
CN103238670A (en) * | 2013-05-14 | 2013-08-14 | 吉林大学 | Milk tablet containing sialic acid and preparation method thereof |
CN104046671A (en) * | 2014-06-24 | 2014-09-17 | 东北农业大学 | Fermentation production method of sialic acid |
CN104041827A (en) * | 2014-06-30 | 2014-09-17 | 江苏布诺堂健康生物科技有限公司 | Microcapsule containing sialic acid and DHA and preparation method thereof |
CN108570484A (en) * | 2017-03-07 | 2018-09-25 | 武汉普赛特膜技术循环利用有限公司 | A method of using fermentation method three times by purification enrichment DHA grease in algae zymotic fluid |
CN107467667A (en) * | 2017-07-17 | 2017-12-15 | 北京亦贝安生物医药科技有限公司 | A kind of compound preparation containing two kinds of unrighted acids and sialic acid |
CN107712050A (en) * | 2017-09-15 | 2018-02-23 | 安徽科技学院 | One kind addition sialic acid and digestible premature labor baby milk powder and preparation method thereof |
CN108486178A (en) * | 2018-02-27 | 2018-09-04 | 广州富诺健康科技股份有限公司 | A kind of preparation method of algae oil DHA |
CN108354174A (en) * | 2018-05-25 | 2018-08-03 | 云南众爱生物科技有限公司 | A kind of Sialic acid soft capsule and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
范群艳等: "微波辅助酶法提取燕窝唾液酸及其益智功能性的研究", 《热带农业科学》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110547456A (en) * | 2019-09-02 | 2019-12-10 | 嘉必优生物技术(武汉)股份有限公司 | carotenoid microcapsule taking sialic acid as coating material and preparation method and application thereof |
CN112493477A (en) * | 2020-11-30 | 2021-03-16 | 嘉必优生物技术(武汉)股份有限公司 | Use of a sialylated oil suspension for the preparation of capsules |
CN112535292A (en) * | 2020-11-30 | 2021-03-23 | 嘉必优生物技术(武汉)股份有限公司 | Sialic acid oil suspension, and preparation method and application thereof |
CN112535292B (en) * | 2020-11-30 | 2022-09-13 | 嘉必优生物技术(武汉)股份有限公司 | Sialic acid oil suspension and preparation method and application thereof |
CN112493477B (en) * | 2020-11-30 | 2022-09-13 | 嘉必优生物技术(武汉)股份有限公司 | Use of a sialylated oil suspension for the preparation of capsules |
CN118147023A (en) * | 2024-05-13 | 2024-06-07 | 山东润德生物科技有限公司 | Composite starter and application thereof in preparation of N-acetylneuraminic acid |
CN118147023B (en) * | 2024-05-13 | 2024-07-19 | 山东润德生物科技有限公司 | Composite starter and application thereof in preparation of N-acetylneuraminic acid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109601980A (en) | A kind of PUFA soft capsule and preparation method thereof containing sialic acid | |
CA2076018C (en) | Docosahexaenoic acid, methods for its production and compounds containing the same | |
FI120648B (en) | Process for the preparation of arachidonic acid | |
CN101892160B (en) | Schizochytrium LX0809 (marine fungus) and industrial application thereof | |
AU2014369341B2 (en) | Methods of recovering oil from microorganisms | |
US9434898B2 (en) | Algal lipid compositions and methods of preparing and utilizing the same | |
CN105586370A (en) | Process For Producing Microbial Fat Or Oil Having Lowered Unsaponifiable Matter Content And Said Fat Or Oil | |
CN109463761A (en) | A kind of PUFA oil suspension and preparation method thereof containing sialic acid | |
CN1986822A (en) | Crypthecodinium connii fermenting process for producing docosahexaenoic acid grease | |
CN101099537A (en) | Omega-3 fatty acid biological feed and its preparing method | |
CN103060212A (en) | Industrial production method for single-cell methanol protein | |
CN101058796B (en) | Composite culture medium for bifidobacterium fermentation and preparation method thereof | |
CN112075532B (en) | Special fat powder for sea fish and preparation method and application thereof | |
CN110747239B (en) | Microbial oil rich in Sn-2 ARA and preparation method and application thereof | |
CN102352400B (en) | Method for producing phytosterol from deodorized distillate of vegetable fat obtained by microbial fermentation | |
CN114164122B (en) | Schizochytrium limacinum with high EPA yield and application thereof | |
CN114134050A (en) | Schizochytrium FR-908 for efficiently accumulating DHA and beta-carotene and preparation method and application thereof | |
CN103484385B (en) | Mortierella alpina mutant strain capable of producing high-yield arachidonic acid, and fermentation method and application thereof | |
CN116622514B (en) | Regulation and control method for improving polyunsaturated fatty acid content in microbial thalli and/or microbial grease and application thereof | |
CN104046661A (en) | Method for preparing biological culture medium obtained by converting rapeseed meal via Neuropara and application of method | |
CN1335094A (en) | Production process of nutrient DHA powder | |
CN104970354A (en) | Functional food for reducing blood fat and blood pressure and two-step fermentation preparation method of functional food | |
LV15474B (en) | Method for producing single cell oil from biodegredable by-products | |
CN108004009A (en) | A kind of Suaeda salsa seed oil and albumen integrated extraction technique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190412 |